Thursday, November 6, 2025
StockstToday.com Logo
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
StocksToday.com Logo
No Result
View All Result
Home Breaking News

Anticipating Freshpets Quarterly Earnings Report Analyst Projections and Investor Expectations

Elaine Mendonca by Elaine Mendonca
February 23, 2024
in Breaking News
0
Investings on laptop and finances
0
SHARES
2
VIEWS
Share on FacebookShare on Twitter

Freshpet (NASDAQ: FRPT) is gearing up to unveil its latest quarterly earnings report on February 26, 2024. Analysts are projecting an earnings per share (EPS) of $0.05 for the company. In the previous quarter, Freshpet exceeded expectations by $0.04, leading to a slight 0.31% decrease in the share price the following day.

Investors are eagerly anticipating Freshpet not only surpassing this estimate but also offering positive guidance for the next quarter. Stock prices are often more significantly influenced by guidance than by earnings beats or misses. As of February 22, the stock was trading at $90.29, marking a 49.33% increase over the past 52 weeks, showcasing promising returns that could enhance long-term investor confidence.

Freshpet’s track record of earnings performance has been a mixed bag, with some quarters exceeding EPS estimates and others falling short, resulting in corresponding price fluctuations. The company’s revenue has been on an upward trajectory year-over-year, and its earnings are forecasted to improve in the upcoming year, transitioning from a loss of ($1.00) per share to ($0.23) per share.

Analysts are predicting Freshpet to report an EPS of 9 cents for the fourth quarter, a significant improvement from a loss of 6 cents per share in the same quarter last year. Investors will be closely monitoring both the earnings outcomes and any guidance provided by Freshpet to assess the company’s future performance and potential stock price movements.

Freshpet Inc. (FRPT) Stock Surges 2.50% on Strong Performance in Market – February 23, 2024

On February 23, 2024, Freshpet Inc. (FRPT) had a strong performance in the stock market. The company’s stock was trading near the top of its 52-week range and was above its 200-day simple moving average, indicating positive price momentum.

The price of FRPT shares saw a significant increase of $2.26 since the market last closed, representing a 2.50% rise in the stock price. The stock opened at $90.29, inline with its previous close, but managed to gain momentum throughout the day and achieve a notable increase in its share price.

Overall, FRPT had a successful trading day on February 23, 2024, with positive price momentum and a significant rise in stock price. Investors who had invested in the company saw their investments grow as the stock performed well in the market. It will be interesting to see how FRPT continues to perform in the coming days and whether it can sustain this positive momentum.

FRPT Stock Performance Analysis on February 23, 2024: Revenue Growth but Declining Net Income

On February 23, 2024, FRPT stock showed some interesting performances based on the data provided by CNN Money. The total revenue for the company was $595.34 million over the past year, which increased by 39.92% compared to the previous year. In the most recent quarter, the total revenue was $200.62 million, showing a 9.43% increase from the previous quarter.

However, despite the growth in revenue, the net income for FRPT was not as positive. The net income for the past year was -$59.49 million, indicating a significant decrease of 100.32% from the previous year. In the most recent quarter, the net income was -$7.17 million, showing a 57.73% increase from the previous quarter.

Earnings per share (EPS) for FRPT also saw some fluctuations. The EPS for the past year was -$1.29, which decreased by 86.18% compared to the previous year. In the most recent quarter, the EPS was -$0.15, showing a 57.78% increase from the previous quarter.

Overall, these financial indicators suggest a mixed performance for FRPT stock on February 23, 2024. Investors may want to closely monitor the company’s financial health and future performance to make informed decisions about their investment in FRPT stock.

Tags: FRPT
Elaine Mendonca

Elaine Mendonca

Related Posts

NFT projects
Breaking News

The Impact of TikToks Fate on USChina Relations and American Tech Giants

March 16, 2024
Businesses finance
Breaking News

Blackstone Strategic Credit 2027 Term Fund BGB Announces Monthly Dividend of 93 Cents per Share

March 15, 2024
Healthcare-sector
Breaking News

Analyzing Short Interest in Molina Healthcare Inc MOH

March 15, 2024
Next Post
Healthcare cloud based

Select Healthcare Corporation Reports Impressive Q4 Results and Approves 108 Billion Buyback Program

Mining Stock Market Today

AngloGold Ashanti Reports Strong Financial Results and New Gold Discovery in FY23

Electric Utilities Stock Exchange

TransAlta Reports Strong Q4 Earnings and Launches Share Buyback Program

Recommended

Nuscale Power Stock

Nuscale Power Shares Surge on Monumental Nuclear Energy Agreement

2 months ago
FLO stock news

Cemtrex Shares Surge After Halting Trading Due to Circuit Breaker

2 years ago
Finance_ Chart Down

Discover the Top 3 Consumer Stocks with Impressive Dividend Yields Unveiled by Wall Streets Most Accurate Analysts

2 years ago
Eli Lilly Stock

Leadership Shift at Eli Lilly as Neuroscience Head Announces Departure

3 months ago

Categories

  • AI & Quantum Computing
  • Analysis
  • Analyst Ratings
  • Asian Markets
  • Automotive & E-Mobility
  • Banking & Insurance
  • Bitcoin
  • Blockchain
  • Bonds
  • Breaking News
  • Business & Industry Trends
  • Cannabis
  • Chemicals
  • Commodities
  • Consumer & Luxury
  • Crypto Stocks
  • Cryptocurrency
  • Cyber Security
  • DAX
  • Defense & Aerospace
  • Dividends
  • Dow Jones
  • E-Commerce
  • Earnings
  • Emerging Markets
  • Energy & Oil
  • ETF
  • Ethereum & Altcoins
  • European Markets
  • Forex
  • Gaming & Metaverse
  • Gold & Precious Metals
  • Healthcare
  • Hydrogen
  • Index
  • Industrial
  • Insider Trading
  • IPOs
  • Market Commentary
  • Market News
  • MDAX & SDAX
  • Mergers & Acquisitions
  • Nasdaq
  • Penny Stocks
  • Pharma & Biotech
  • Real Estate & REITs
  • Renewable Energy
  • S&P 500
  • Semiconductors
  • Space
  • Stock Picks
  • Stock Targets
  • Stocks
  • TecDAX
  • Tech & Software
  • Telecommunications
  • Trading & Momentum
  • Turnaround
  • Uncategorized
  • Value & Growth

Topics

Adobe Alibaba Alphabet Amazon AMD Apple Applovin BioNTech Broadcom Coinbase D-Wave Quantum Eli Lilly Fiserv IBM Intel Kraft Heinz Lockheed Marvell Technology META Micron Microsoft MP Materials MSCI World ETF NIO Nvidia Ocugen Opendoor Oracle Oxford Lane Capital Palantir PayPal Plug Power QuantumScape Realty Income Robinhood Rocket Lab USA Salesforce Strategy Super Micro Computer Tesla Tilray Unitedhealth Uranium Energy Viking Therapeutics Wolfspeed
No Result
View All Result

Highlights

Iovance Faces Critical Test as Q3 Earnings Approach

DuPont Faces Critical Test as Quarterly Results Loom

Sarepta Therapeutics Shares Plummet Following Critical Clinical Trial Failure

Emerson Electric’s Strategic Pivot Faces Market Scrutiny

EU Grant Provides Critical Boost for LanzaTech’s Carbon Recycling Technology

Is Darden Restaurants Facing a Critical Test?

Trending

Eastman Chemical Stock
Chemicals

Eastman Chemical’s Challenging Quarter: A Deep Dive into the Numbers

by Dieter Jaworski
November 6, 2025
0

Eastman Chemical Company finds itself navigating turbulent waters as the global specialty chemicals sector faces significant headwinds....

BioNTech Stock

BioNTech’s Crossroads: Navigating Losses Amid Cancer Research Promise

November 6, 2025
Illumina Stock

China Lifts Export Ban on Illumina’s DNA Sequencers, Sparking Market Rally

November 6, 2025
Iovance Stock

Iovance Faces Critical Test as Q3 Earnings Approach

November 6, 2025
DuPont de Nemours Stock

DuPont Faces Critical Test as Quarterly Results Loom

November 6, 2025

StocksToday.com is your one-stop destination for the latest stock news and analysis. We provide in-depth coverage of the stock market, including market news, company news, sector news, IPO news, investment strategies, personal finance, international markets, and more.

Follow us on social media:

Recent News

  • Eastman Chemical’s Challenging Quarter: A Deep Dive into the Numbers
  • BioNTech’s Crossroads: Navigating Losses Amid Cancer Research Promise
  • China Lifts Export Ban on Illumina’s DNA Sequencers, Sparking Market Rally

Category

  • About
  • Advertise
  • Careers
  • Contact
  • Imprint
  • Privacy Policy
  • Terms of Service

© 2023 StocksToday.com

No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing

© 2023 StocksToday.com